Annovis Total Assets from 2010 to 2025

ANVS Stock

USD 1.75 0.05 2.78%

Annovis Bio Total Assets yearly trend continues to be comparatively stable with very little volatility. Total Assets are likely to outpace its year average in 2025. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2012-12-31

Previous Quarter

5 M

Current Value

14.4 M

Quarterly Volatility

16.6 M

Yuan Drop

Covid

Check Annovis Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Annovis Bio's main balance sheet or income statement drivers, such as Interest Expense of 199.6 K, Selling General Administrative of 7.5 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.0069. Annovis financial statements analysis is a perfect complement when working with Annovis Bio Valuation or Volatility modules.

Check out the analysis of Annovis Bio Correlation against competitors.

For more information on how to buy Annovis Stock please use our How to Invest in Annovis Bio guide.

Latest Annovis Bio's Total Assets Growth Pattern

Below is the plot of the Total Assets of Annovis Bio over the last few years. Total assets refers to the total amount of Annovis Bio assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Annovis Bio books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Annovis Bio's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Annovis Bio's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 10.21 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Annovis Total Assets Regression Statistics

	Arithmetic Mean	9,709,368
	Geometric Mean	2,325,342
	Coefficient Of Variation	142.96
	Mean Deviation	10,207,414
	Median	2,835,221
	Standard Deviation	13,880,628
	Sample Variance	192.7T
	Range	46M
	R-Value	0.43
	Mean Square Error	169.1T
	R-Squared	0.18
	Significance	0.10
	Slope	1,239,559
	Total Sum of Squares	2890.1T

Annovis Total Assets History

	2025	14.9 M
	2024	11.7 M
	2023	10.2 M
	2022	36 M
	2021	46 M
	2020	8.1 M
	2019	1.1 M

Other Fundumenentals of Annovis Bio

Intangibles To Total Assets

Annovis Bio Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment	Good Will	Net Debt	Capital Surpluse	Net Invested Capital	Net Working Capital	Capital Stock	Long Term Debt	Long Term Debt Total	Deferred Long Term Liab
Total Assets		0.89	0.72	-0.34	0.52	0.21	0.0	0.99	0.12	-0.15	0.22	-0.16	-0.92	0.67	0.87	0.93	0.59	-0.11	-0.11	-0.11
Total Stockholder Equity	0.89		0.39	0.06	0.4	0.22	-0.45	0.88	0.26	0.01	0.22	0.04	-0.89	0.33	0.93	0.84	0.31	0.24	0.24	0.24
Net Tangible Assets	0.72	0.39		-0.88	0.32	-0.06	0.57	0.73	-0.24	-0.14	-0.05	-0.21	-0.61	0.99	0.44	0.7	0.91	-0.59	-0.59	-0.59
Retained Earnings	-0.34	0.06	-0.88		-0.16	0.16	-0.82	-0.36	0.39	0.21	0.16	0.3	0.23	-0.89	-0.04	-0.33	-0.85	0.64	0.64	0.64
Accounts Payable	0.52	0.4	0.32	-0.16		0.82	0.16	0.41	0.69	-0.13	0.84	-0.15	-0.16	0.2	0.16	0.18	0.15	-0.05	-0.05	-0.05
Net Receivables	0.21	0.22	-0.06	0.16	0.82		-0.06	0.08	0.81	-0.2	0.98	-0.21	0.12	-0.2	-0.09	-0.14	-0.2	0.12	0.12	0.12
Total Liab	0.0	-0.45	0.57	-0.82	0.16	-0.06		0.0	-0.33	-0.34	-0.03	-0.41	0.15	0.6	-0.34	-0.04	0.5	-0.72	-0.72	-0.72
Total Current Assets	0.99	0.88	0.73	-0.36	0.41	0.08	0.0		-0.01	-0.17	0.09	-0.18	-0.96	0.71	0.91	0.97	0.63	-0.1	-0.1	-0.1
Intangible Assets	0.12	0.26	-0.24	0.39	0.69	0.81	-0.33	-0.01		0.35	0.87	0.36	0.15	-0.38	-0.08	-0.2	-0.37	0.33	0.33	0.33
Common Stock	-0.15	0.01	-0.14	0.21	-0.13	-0.2	-0.34	-0.17	0.35		-0.11	0.98	0.13	-0.2	-0.11	-0.15	-0.2	0.1	0.1	0.1
Property Plant Equipment	0.22	0.22	-0.05	0.16	0.84	0.98	-0.03	0.09	0.87	-0.11		-0.12	0.11	-0.18	-0.09	-0.13	-0.18	0.1	0.1	0.1
Good Will	-0.16	0.04	-0.21	0.3	-0.15	-0.21	-0.41	-0.18	0.36	0.98	-0.12		0.12	-0.26	-0.07	-0.14	-0.29	0.17	0.17	0.17
Net Debt	-0.92	-0.89	-0.61	0.23	-0.16	0.12	0.15	-0.96	0.15	0.13	0.11	0.12		-0.61	-0.97	-0.99	-0.56	-0.03	-0.03	-0.03
Capital Surpluse	0.67	0.33	0.99	-0.89	0.2	-0.2	0.6	0.71	-0.38	-0.2	-0.18	-0.26	-0.61		0.45	0.7	0.93	-0.6	-0.6	-0.6
Net Invested Capital	0.87	0.93	0.44	-0.04	0.16	-0.09	-0.34	0.91	-0.08	-0.11	-0.09	-0.07	-0.97	0.45		0.94	0.43	0.18	0.18	0.18
Net Working Capital	0.93	0.84	0.7	-0.33	0.18	-0.14	-0.04	0.97	-0.2	-0.15	-0.13	-0.14	-0.99	0.7	0.94		0.62	-0.13	-0.13	-0.13
Capital Stock	0.59	0.31	0.91	-0.85	0.15	-0.2	0.5	0.63	-0.37	-0.2	-0.18	-0.29	-0.56	0.93	0.43	0.62		-0.4	-0.4	-0.4
Long Term Debt	-0.11	0.24	-0.59	0.64	-0.05	0.12	-0.72	-0.1	0.33	0.1	0.1	0.17	-0.03	-0.6	0.18	-0.13	-0.4		1.0	1.0
Long Term Debt Total	-0.11	0.24	-0.59	0.64	-0.05	0.12	-0.72	-0.1	0.33	0.1	0.1	0.17	-0.03	-0.6	0.18	-0.13	-0.4	1.0		1.0
Deferred Long Term Liab	-0.11	0.24	-0.59	0.64	-0.05	0.12	-0.72	-0.1	0.33	0.1	0.1	0.17	-0.03	-0.6	0.18	-0.13	-0.4	1.0	1.0

Click cells to compare fundamentals

About Annovis Bio Financial Statements

Annovis Bio shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although Annovis Bio investors may analyze each financial statement separately, they are all interrelated. The changes in Annovis Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on Annovis Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

		Last Reported	Projected for Next Year
	Total Assets	11.7 M	14.9 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Annovis Stock Analysis

When running Annovis Bio's price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC